These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8594307)

  • 21. No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
    Frille A; Leithner K; Olschewski A; Olschewski H; Wohlkönig C; Hrzenjak A
    Int J Oncol; 2018 Feb; 52(2):518-526. PubMed ID: 29345289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the erythropoietin receptor on a human myeloma cell line.
    Okuno Y; Takahashi T; Suzuki A; Ichiba S; Nakamura K; Hitomi K; Sasaki R; Imura H
    Biochem Biophys Res Commun; 1990 Aug; 170(3):1128-34. PubMed ID: 2167671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo and in vitro regulation of erythropoietin mRNA: measurement by competitive polymerase chain reaction.
    Fandrey J; Bunn HF
    Blood; 1993 Feb; 81(3):617-23. PubMed ID: 8381307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythropoietin is a JAK2 and ERK1/2 effector that can promote renal tumor cell proliferation under hypoxic conditions.
    Miyake M; Goodison S; Lawton A; Zhang G; Gomes-Giacoia E; Rosser CJ
    J Hematol Oncol; 2013 Sep; 6():65. PubMed ID: 24004818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localization of specific erythropoietin binding sites in defined areas of the mouse brain.
    Digicaylioglu M; Bichet S; Marti HH; Wenger RH; Rivas LA; Bauer C; Gassmann M
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3717-20. PubMed ID: 7731971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.
    Wang GL; Semenza GL
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4304-8. PubMed ID: 8387214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma.
    Acs G; Zhang PJ; Rebbeck TR; Acs P; Verma A
    Cancer; 2002 Sep; 95(5):969-81. PubMed ID: 12209679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of erythropoietin production in a hepatocellular carcinoma cell line.
    Nakashima J; Brookins J; Fisher JW
    J Lab Clin Med; 1992 Mar; 119(3):306-14. PubMed ID: 1311742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Why is erythropoietin present in human milk? Studies of erythropoietin receptors on enterocytes of human and rat neonates.
    Juul SE; Joyce AE; Zhao Y; Ledbetter DJ
    Pediatr Res; 1999 Sep; 46(3):263-8. PubMed ID: 10473039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of hydrogen peroxide in hypoxia-induced erythropoietin production.
    Fandrey J; Frede S; Jelkmann W
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):507-10. PubMed ID: 7980410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
    Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
    Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythropoietin and erythropoietin receptor in the developing human central nervous system.
    Juul SE; Anderson DK; Li Y; Christensen RD
    Pediatr Res; 1998 Jan; 43(1):40-9. PubMed ID: 9432111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells.
    Masuda S; Nagao M; Takahata K; Konishi Y; Gallyas F; Tabira T; Sasaki R
    J Biol Chem; 1993 May; 268(15):11208-16. PubMed ID: 7684373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulators of protein kinase C inhibit hypoxia-induced erythropoietin production.
    Faquin WC; Schneider TJ; Goldberg MA
    Exp Hematol; 1993 Mar; 21(3):420-6. PubMed ID: 7679999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythropoietin and erythropoietin receptor expression in human cancer.
    Acs G; Acs P; Beckwith SM; Pitts RL; Clements E; Wong K; Verma A
    Cancer Res; 2001 May; 61(9):3561-5. PubMed ID: 11325818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and modulation of specific, high affinity binding sites for erythropoietin on the human erythroleukemic cell line K562.
    Fraser JK; Lin FK; Berridge MV
    Blood; 1988 Jan; 71(1):104-9. PubMed ID: 2825843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythropoietin: physiology and pharmacology update.
    Fisher JW
    Exp Biol Med (Maywood); 2003 Jan; 228(1):1-14. PubMed ID: 12524467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of erythropoietin production by cytokines. Implications for the anemia involved in inflammatory states.
    Jelkmann WE; Fandrey J; Frede S; Pagel H
    Ann N Y Acad Sci; 1994 Apr; 718():300-9; discussion 309-11. PubMed ID: 8185237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma.
    Mohyeldin A; Lu H; Dalgard C; Lai SY; Cohen N; Acs G; Verma A
    Neoplasia; 2005 May; 7(5):537-43. PubMed ID: 15967106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo and in vitro erythropoietin activities in cultures of a hepatocellular carcinoma cell line.
    Nakashima J; Brookins J; Beckman B; Ohigashi T; Fisher JW
    Proc Soc Exp Biol Med; 1993 May; 203(1):84-91. PubMed ID: 8386383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.